Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$183,846,126
-$71,884,750 QoQ
Shares Held
7,634,806
-16.2% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#69
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. PFE ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
37,816,285 | $267,739,296 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,910,947 | $245,556,688 | |
| 3 | PFE |
Pfizer Inc
This page
|
7,634,806 | $183,846,126 | |
| 4 | SNY |
Sanofi
|
4,136,417 | $176,459,547 | |
| 5 | GSK |
GSK plc
|
1,483,198 | $77,749,239 | |
| 6 | JNJ |
Johnson & Johnson
|
276,623 | $70,253,942 | |
| 7 | NVS |
Novartis AG
|
197,593 | $30,966,774 | |
| 8 | OGN |
Organon & Co.
|
729,502 | $9,877,456 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,846,126 | 7,634,806 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $255,730,876 | 9,107,225 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $214,866,629 | 8,629,182 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $214,357,403 | 8,412,771 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $194,955,265 | 8,042,709 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $178,648,822 | 7,050,072 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $177,967,589 | 6,708,164 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $166,269,761 | 5,745,327 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $155,940,429 | 5,573,282 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $140,319,762 | 5,056,568 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $124,800,302 | 4,334,849 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $98,097,719 | 2,957,423 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $104,113,024 | 2,838,414 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $98,391,606 | 2,411,559 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $101,433,166 | 1,979,570 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $100,701,561 | 2,301,224 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $119,089,239 | 2,271,395 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $117,528,460 | 2,270,204 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $128,210,657 | 2,171,222 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $103,404,813 | 2,404,204 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $91,774,905 | 2,343,588 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $67,493,228 | 1,862,910 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $65,864,021 | 1,789,297 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $66,247,360 | 1,805,107 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $66,511,834 | 2,033,999 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $74,695,330 | 2,288,463 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||